Articles From: F5 Introduces Next Wave of Software Defined Application Services to Infinity and AbbVie Announce Global Strategic Collaboration to Develop and Commercialize Duvelisib (IPI-145) In Oncology


F5 Networks (NASDAQ: FFIV ) today introduced new Software Defined Application Services ™ (SDAS ™ ) for its physical and virtual BIG-IP ® solutions, extending the company’s access, security, and acceleration technologies for the highest levels of scale and performance.
Sign-up for F5 Introduces Next Wave of Software Defined Application Services investment picks
PETACH TIKVA, Israel , Sept.
Sign-up for Can-Fite to Present at Rodman & Renshaw Global Investment Conference in New York City on September 9, 2014 investment picks
eBay, ChannelAdvisor veteran charged with deepening RetailMeNot's relationships with the largest retailers and brands AUSTIN, Texas , Sept.
Sign-up for RetailMeNot, Inc. Names Michael Jones as Senior Vice President, Retailer and Brand Solutions investment picks
Ranking Based on User Ratings and Market Segment Adoption RESTON, Va.
Sign-up for comScore Rated Strong Performer in TrustRadius Digital Analytics TrustMap™ for Enterprises investment picks
Avnet Electronics Marketing , an operating group of Avnet, Inc .
Sign-up for Avnet Electronics Marketing Releases PicoZed System-On-Module investment picks
Coca-Cola Enterprises (NYSE: CCE)(Euronext Paris: CCE) will discuss its plans and outlook with investors today at the Barclays Back-to-School Consumer Conference in Boston at 2:15 p.m. ET.
Sign-up for CCE Presents at Barclays Back-to-School Investor Conference, Provides Full-Year 2014 Guidance investment picks
2014/9/3
Concordia Healthcare Announces Agreement to Acquire Zonegran® in the United States and Puerto Rico Canada NewsWire "The acquisition of Zonegran for commercialization in the United States and Puerto Rico represents another advancement in the execution of Concordia's legacy product strategy, which management believes will provide significant and sustainable revenue going forward," said Mark Thompson , CEO of Concordia .
Sign-up for Concordia Healthcare Announces Agreement to Acquire Zonegran® in the United States and Puerto Rico investment picks
2014/9/3
Couche-Tard Sells its Aviation Fuel Business Canada NewsWire About Alimentation Couche-Tard Inc. Couche-Tard is the leader in the Canadian convenience store industry.
Sign-up for Couche-Tard Sells its Aviation Fuel Business investment picks
2014/9/3
LAVAL, QC , Sept.
Sign-up for Couche-Tard Sells its Aviation Fuel Business investment picks
Gupta Technologies , a global provider of application development, database and migration software, today announced a successful deployment of a mobile application using TD Mobile by the Friends of Israel (FOI) organization.
Sign-up for Gupta Technologies’ TD Mobile Enables Non-profit Organization, Friends of Israel, Access to Critical Data from Mobile Devices While in the Field investment picks
Redknee Signs $6 Million Dollar Order with Tier 1 APAC Operator Canada NewsWire TORONTO , Sept.
Sign-up for Redknee Signs $6 Million Dollar Order with Tier 1 APAC Operator investment picks
Kohl’s Department Stores (NYSE: KSS) and AwesomenessTV today announced a partnership to launch S.o. R.a.d., a seven capsule limited-edition junior’s fashion line and Life’s S.o. R.a.d. , an original four season YouTube series featuring top teen influencers.
Sign-up for Kohl’s Department Stores Partners with AwesomenessTV on Breakthrough New Fashion Line and Original YouTube Series investment picks
First molecular test indicated for samples from both males and females SUNNYVALE, Calif.
Sign-up for Cepheid Announces European Release of Xpert TV, a Next-Generation Molecular Test for Rapid and Accurate Identification of Trichomonas vaginalis Infections investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G020932-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/9/2/11G020932/logo-1384140982526.jpg BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - September 03, 2014) - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F.
Sign-up for Amarin to Present at the Rodman & Renshaw 2014 Global Investment Conference investment picks
Cipher Pharmaceuticals Inc. to present at Rodman & Renshaw 16th Annual Global Investment Conference Canada NewsWire MISSISSAUGA, ON , Sept.
Sign-up for Cipher Pharmaceuticals Inc. to present at Rodman & Renshaw 16th Annual Global Investment Conference investment picks
http://media.marketwire.com/attachments/201402/227789_CBLI_logo2012.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1141649&ProfileId=051205&sourceType=1 BUFFALO, NY --
Sign-up for Cleveland BioLabs Announces Green Light to Submit Pre-Emergency Use Authorization Application for Entolimod investment picks
The randomized, double-blind, placebo-controlled, parallel group Phase III study with RHB-102 (the GUARD study) will enroll 320 acute gastroenteritis patients in the U.S. Acute gastroenteritis is an inflammation of the gastrointestinal tract causing nausea and vomiting, with a potential worldwide market estimated to exceed $650 million If approved for marketing by the FDA, RHB-102 is expected to be the first-ever 5-HT3 antagonist drug indicated for acute gastroenteritis Dr.
Sign-up for RedHill Biopharma Initiates Phase III Study of RHB-102 for Gastroenteritis investment picks
INTERXION HOLDING NV (NYSE: INXN), a leading European provider of cloud and carrier-neutral colocation data centre services, today announced that in response to continued customer demand, it will construct its fourth data centre in Stockholm (“STO4”), and further expand its VIE2 data centre in Vienna.
Sign-up for Interxion to Build Fourth Data Centre in Stockholm and to Expand in Vienna investment picks
Prostate Cancer Awareness Month in September Promotes Importance of Early Detection to Save Men's Lives MELVILLE, N.Y. , Sept.
Sign-up for Henry Schein And LUGPA Encourage Families To Put Dad On Their Back To School List For Prostate Check-Ups investment picks
Exchange Income Corporation announces 3 year AT&T contract extension Canada NewsWire WINNIPEG , Sept.
Sign-up for Exchange Income Corporation announces 3 year AT&T contract extension investment picks
2014/9/3
Staples, one of the world’s largest internet retailers, today announced a series of enhancements to its omnichannel experience, making it even easier for customers to get all the products and services they need to make more happen with their businesses.
Sign-up for Staples Launches Series of Omnichannel Updates to Help Businesses Make More Happen investment picks
STAMFORD, Conn.
Sign-up for Dorian LPG Ltd. Announces First Quarter 2015 Financial Results investment picks
2014/9/3
Oryx Petroleum Resumes Operations in the Kurdistan Region of Iraq Canada NewsWire Full Resumption of Production, Sales, Development Drilling and Facilities Construction at Demir Dagh CALGARY , Sept.
Sign-up for Oryx Petroleum Resumes Operations in the Kurdistan Region of Iraq investment picks
2014/9/3
By Sarah Sloat FRANKFURT--German retailer association HDE on Wednesday confirmed its outlook for a 1.5% rise in sales this year, with online shopping fueling overall growth and triggering structural change in the sector.
Sign-up for German Retailers Still See Slight Sales Growth in 2014, Propped Up by Online investment picks
- Infinity to Receive $275 Million Upfront Payment and $530 Million in Potential Milestones - - Companies to Jointly Develop and Commercialize Duvelisib in U.S., with Equal Profit Share; Infinity to Receive Royalties on Sales Outside the U.S. - - Infinity to Host Conference Call Today at 8:30 A.M. ET/7:30 A.M. CT - CAMBRIDGE, Mass.
Sign-up for Infinity And AbbVie Announce Global Strategic Collaboration To Develop And Commercialize Duvelisib (IPI-145) In Oncology investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) and AbbVie Inc. (NYSE: ABBV) today announced that they have entered into a global collaboration to develop and commercialize duvelisib (IPI-145), Infinity’s oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, for the treatment of patients with cancer.
Sign-up for Infinity and AbbVie Announce Global Strategic Collaboration to Develop and Commercialize Duvelisib (IPI-145) In Oncology investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: F5 Introduces Next Wave of Software Defined Application Services to Infinity and AbbVie Announce Global Strategic Collaboration to Develop and Commercialize Duvelisib (IPI-145) In Oncology
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices